Literature DB >> 1081000

Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions.

E S Jaffe, E M Shevach, E H Sussman, M Frank, I Green, C W Berard.   

Abstract

The cells of the lymphoreticular system are heterogeneous both morphologically and functionally. The bone marrow derived (B) lymphocyte can be identified by the presence of easily detectable surface immunoglobulin and a receptor for antigen-antibody-complement (EAC) complexes. Monocytes and histiocytes also bear a receptor for EAC and in addition possess a receptor for cytophilic antibody detected with red cell--IgG complexes (IgGEA). In man, thymus derived (T) lymphocytes form non-immune rosettes with sheep red blood cells (E). We have examined a number of malignant lymphoreticular populations for the presence of the EAC, EA, and E receptors on suspensions of cells and have adapted the technique to demonstrate the EAC and EA receptors on frozen tissue sections. Rosetted malignant cells can also be cytologically examined on Millipore filters. The malignant cells both in section and suspension from the spleens and lymph nodes of 6 patients with nodular lymphoma bound EAC but not IgGEA or E; by these criteria these malignant cells are of B lymphocytic origin. The malignant cells from the spleens of 2 patients with leukaemic reticuloendotheliosis and 1 patient with malignant histiocytosis could be classified as being of histiocytic origin by the selective binding of IgGEA. In 3 cases of diffuse lymphocytic lymphoma the malignant cells bound only E and are therefore of T lymphocytic origin. The application of these techniques to the classification of malignant lymphoma may lead to important theoretical and therapeutic advances.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081000      PMCID: PMC2149577     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  25 in total

1.  Malignant Lymphoma: A Clinico-Pathologic Survey of 618 Cases.

Authors:  E A Gall; T B Mallory
Journal:  Am J Pathol       Date:  1942-05       Impact factor: 4.307

Review 2.  Receptors for complement and immunoglobulin on human and animal lymphoid cells.

Authors:  E M Shevach; E S Jaffe; I Green
Journal:  Transplant Rev       Date:  1973

3.  Nodular lymphoma--evidence for origin from follicular B lymphocytes.

Authors:  E S Jaffe; E M Shevach; M M Frank; C W Berard; I Green
Journal:  N Engl J Med       Date:  1974-04-11       Impact factor: 91.245

4.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

5.  Receptor sites of human monocytes for IgG.

Authors:  H Huber; H H Fudenberg
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

Review 6.  Lymphocytes and the immune response. 2.

Authors:  C G Craddock; R Longmire; R McMillan
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

7.  Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes.

Authors:  P Dukor; C Bianco; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

8.  Chronic reticulolymphocytic leukemia. Reclassification of "leukemic reticuloendotheliosis" through functional characterization of the circulating mononuclear cells.

Authors:  A D Rubin; S D Douglas; L N Chessin; P R Glade; W Dameshek
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

9.  Two distinct populations of peripheral lymphocytes in mice distinguishable by immunofluorescence.

Authors:  M C Raff
Journal:  Immunology       Date:  1970-10       Impact factor: 7.397

10.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  18 in total

1.  Cytogenetic and cell-surface marker studies in two non-Hodgkin's lymphomata of T-cell origin.

Authors:  B R Reeves; G Stathopoulos
Journal:  Hum Genet       Date:  1976-02-29       Impact factor: 4.132

2.  Evidence for monoclonal proliferation in prolymphocytic leukemia of T-cell orgin. A cytogenetic and Quantitative immunoautoradiographic analysis.

Authors:  E Thiel; M Bauchinger; H Rodt; D Huhn; H Theml; S Thierfelder
Journal:  Blut       Date:  1977-12

Review 3.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

4.  T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review.

Authors:  T L Whiteside; D T Rowlands
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

5.  Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes.

Authors:  J J van den Oord; C de Wolf-Peeters; R De Vos; V J Desmet
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

6.  A case of histiocytic medullary reticulosis (HMR): response to combination chemotherapy.

Authors:  S R McCann; H Daly; D G Weir; I J Temperley
Journal:  Ir J Med Sci       Date:  1980-01       Impact factor: 1.568

7.  Morphology of lymphatic cells and of their derived tumours.

Authors:  F Rilke; S Pilotti; A Carbone; L Lombardi
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

8.  Distribution of T-lymphocytes in follicular lymphomas as revealed by acid alpha-naphthol acetate esterase.

Authors:  C S Papadimitriou; N X Papacharalampous
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

9.  Localization of human T lymphocytes in tissue sections by a rosetting technique.

Authors:  D B Brubaker; T L Whiteside
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

10.  Immunologic surface markers in non-Hodgkin's lymphomas.

Authors:  J Cossman; B Schnitzer; M J Deegan
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.